![Pascal Birman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Pascal Birman is currently the Chief Medical Officer at PHAXIAM Therapeutics SA since 2023.
Prior to this, he worked as the Medical Director at Pherecydes Pharma SA and as the Deputy Chief Medical Officer at Genfit SA.
Actieve functies van Pascal Birman
| Bedrijven | Functie | Begin |
|---|---|---|
| PHAXIAM THERAPEUTICS S.A. | Hoofd Techniek/Wetenschap/O&O | 23-06-2023 |
Eerdere bekende functies van Pascal Birman
| Bedrijven | Functie | Einde |
|---|---|---|
| GENFIT | Corporate Officer/Principal | - |
| PHERECYDES PHARMA | Hoofd Techniek/Wetenschap/O&O | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Genfit SA
 Genfit SA BiotechnologyHealth Technology Engages in research and development of medicines and diagnostic solutions | Health Technology |
Pherecydes Pharma SA
 Pherecydes Pharma SA Pharmaceuticals: MajorHealth Technology Specializes in nano technologies for pharmaceutical purposes | Health Technology |
PHAXIAM Therapeutics SA
 PHAXIAM Therapeutics SA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops red blood cell-based therapeutics for severe forms of cancer & orphan diseases | Health Technology |
Kies MarketScreener 
